Cough: potential pharmacological developments

被引:11
作者
Chung, KF
机构
[1] Royal Brompton & Harefield NHS Trust, London SW3, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3, England
关键词
antitussive; capsaicin; cough; cough receptor; cough reflex; neurokinin receptor antagonist; nociceptin; opioids; vannilioid receptor;
D O I
10.1517/13543784.11.7.955
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cough is an important defensive reflex of the upper airway and is also a very common symptom of respiratory disease. Cough following an upper respiratory viral infection is transient, and persistent cough is associated with a whole range of conditions, such as asthma, rhino-sinusitis and gastrooesophageal reflux. Treatment directed at these conditions may improve the associated cough. There is often a need, however, to control cough itself whatever the cause. The most effective drugs in this class are the opioids, such as morphine, codeine or pholcodeine, but at effective doses they have side effects including drowsiness, nausea, constipation and physical dependence. Investigations into the cough reflex and into the potential mechanisms of sensitised cough reflex have uncovered several potential targets for novel drugs. New opioids apart from mu-agonists such as kappa- and delta-receptor agonists, have been developed, in addition to non-opioids such as nociceptin. Neurokinin receptor antagonists, bradykinin receptor antagonists, vanniloid receptor VR-1 antagonists may be beneficial by blocking effects of tachykinins and sensory nerve activation. Local anaesthetics, blockers of sodium-dependent channels and maxi-K Ca2+-dependent channel activators of afferent nerves are inhibitors of the cough reflex. Some of these novel agents may act centrally or peripherally or at both sites as antitussives. Large scale trials of these novel compounds have not been carried out in cough in man but there is a serious need for more effective antitussives devoid of side effects.
引用
收藏
页码:955 / 963
页数:9
相关论文
共 79 条
[1]   EFFECTS OF CODEINE, MORPHINE AND A NOVEL OPIOID PENTAPEPTIDE-BW443C, ON COUGH, NOCICEPTION AND VENTILATION IN THE UNANESTHETIZED GUINEA-PIG [J].
ADCOCK, JJ ;
SCHNEIDER, C ;
SMITH, TW .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (01) :93-100
[2]   ANTITUSSIVE EFFECT OF SR 48968, A NONPEPTIDE TACHYKININ NK(2) RECEPTOR ANTAGONIST [J].
ADVENIER, C ;
GIRARD, V ;
NALINE, E ;
VILAIN, P ;
EMONDSALT, X .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (01) :169-171
[3]   Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma [J].
Alton, EWFW ;
Norris, AA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (05) :S102-S105
[4]   Sensory receptor activation by mediators of defense reflexes in guinea-pig lungs [J].
Bergren, DR .
RESPIRATION PHYSIOLOGY, 1997, 108 (03) :195-204
[5]   Bradykinin antagonists: new opportunities [J].
Bock, MG ;
Longmore, J .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (04) :401-406
[6]   Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat [J].
Bolser, DC ;
DeGennaro, FC ;
OReilly, S ;
McLeod, RL ;
Hey, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) :165-170
[7]   Mechanisms of action of central and peripheral antitussive drugs [J].
Bolser, DC .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1996, 9 (5-6) :357-364
[8]   ANTITUSSIVE EFFECTS OF GABA(B) AGONISTS IN THE CAT AND GUINEA-PIG [J].
BOLSER, DC ;
AZIZ, SM ;
DEGENNARO, FC ;
KREUTNER, W ;
EGAN, RW ;
SIEGEL, MI ;
CHAPMAN, RW .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) :491-495
[9]   PERIPHERAL AND CENTRAL SITES OF ACTION OF GABA-B AGONISTS TO INHIBIT THE COUGH REFLEX IN THE CAT AND GUINEA-PIG [J].
BOLSER, DC ;
DEGENNARO, FC ;
OREILLY, S ;
CHAPMAN, RW ;
KREUTNER, W ;
EGAN, RW ;
HEY, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1344-1348
[10]   Antitussive action of nociceptin in the cat [J].
Bolser, DC ;
McLeod, RL ;
Tulshian, DB ;
Hey, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 430 (01) :107-111